Okayama University established the Institute for Emerging Medical Innovation in April 2026 and held an unveiling ceremony for the institute’s new signboard on April 6 in front of the Clinical Research Building at the Shikata Campus.

The institute was established to integrate Okayama University’s longstanding strengths in clinical research, regenerative medicine, and radiopharmaceutical research, and to promote the creation of advanced and interdisciplinary medical technologies through cross-disciplinary collaboration. It aims to serve as a leading research hub from Japan that will drive innovation in global healthcare, contribute to extending healthy life expectancy, reducing medical costs, and expanding Japanese medical technologies worldwide.

During the unveiling ceremony, President NASU Yasutomo, Vice Executive Director TOYOOKA Shinichi (New Medical Research Hub), and Institute Director TAKARADA Takeshi jointly unveiled the new signboard.

Following the unveiling, President Nasu, Vice Executive Director Toyooka, and Director Takarada each delivered remarks. President Nasu expressed his expectations for the institute’s future, stating:
“We intend to share a wide range of resources to further expand this institute, and we are planning various initiatives. I hope that, together with all of you, we can create our future.”

The Institute for Emerging Medical Innovation will continue to advance cutting-edge medical innovation and foster collaboration that contributes to the future of healthcare.

○ Visit the Institute for Emerging Medical Innovation website

―――――
Please note that this content was translated by a machine and may contain errors.